In the framework of the epigenetic switch linking inflammation to cancer, the model indicates that Ras acts as an oncogene by moving the threshold leading to cell transformation to smaller levels of the inflammatory signal, Src (see Fig. 4 when VSMRAS increases from 0 to 0.027). This evidence concerns the gene SRC and cancer.